Expand BHC Menu
BHC MENU

BHC Latest Press Releases

-- April 11, 2024 --

Bausch Health to Announce First-Quarter 2024 Results on May 2 ACCESSWIRE 4:23 PM
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029 ACCESSWIRE 1:05 PM
Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan ACCESSWIRE 8:02 AM

-- April 5, 2024 --

Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals ACCESSWIRE 6:15 PM

-- April 3, 2024 --

Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults ACCESSWIRE 8:03 AM

-- April 2, 2024 --

Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations ACCESSWIRE 8:03 AM

-- March 6, 2024 --

Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma ACCESSWIRE 8:02 AM

-- March 5, 2024 --

New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure ACCESSWIRE 8:02 AM

-- March 1, 2024 --

Bausch Health Companies to Present at Cowen Annual Health Care Conference ACCESSWIRE 8:03 AM

-- February 22, 2024 --

Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results ACCESSWIRE 7:05 AM

-- February 1, 2024 --

Bausch Health Announces Board Refreshment ACCESSWIRE 4:13 PM
Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 ACCESSWIRE 8:01 AM

-- January 30, 2024 --

CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. ACCESSWIRE 8:03 AM

-- January 18, 2024 --

CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China ACCESSWIRE 4:51 PM
Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China ACCESSWIRE 8:03 AM

-- January 8, 2024 --

Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute ACCESSWIRE 11:16 AM

-- December 21, 2023 --

Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis ACCESSWIRE 7:02 AM

-- December 18, 2023 --

DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec's Public Drug Plan ACCESSWIRE 8:01 AM

-- December 5, 2023 --

Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day ACCESSWIRE 8:02 AM